Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Laryngotracheal Stenosis Using Autologous Olfactory-mucosa-derived Mesenchymal Stem Cells

NCT05535803 is registered in ClinicalTrials.gov with Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus as lead sponsor.

NCT NCT05535803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05535803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Laryngotracheal Stenosis Using Autologous Olfactory-mucosa-derived Mesenchymal Stem Cells
Lead sponsor
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Phase
Phase 2
Overall status
Unknown status
Start date
June 1, 2021
Completion date
June 30, 2023
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

laryngeal stenosis, tracheal stenosis